%0 Journal Article
%T Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
%A Akihiko Kitoh
%A Atsushi Otsuka
%A Chisa Nakashima
%A Judith A. Seidel
%A Kenji Kabashima
%A Megumi Aoki
%A Naohito Hatta
%A Saeko Nakajima
%A Satoshi Fukushima
%A Satoshi Koreeda
%A Shigeto Matsushita
%A Taku Fujimura
%A Tatsuya Takenouchi
%A Teruki Dainichi
%A Tetsuya Honda
%A Yu Sawada
%A Yumi Nonomura
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1248327
%K Anti-PD-1 antibody
%K melanoma
%K nivolumab
%K Th9
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215264/